Axa
ALXO icon

Axa’s ALX Oncology ALXO Stock Holding History

Axa’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-124,199
Closed -$2.1M – 1109
2022
Q1 		$2.1M Buy
124,199
+1
+0% +$17 0.01% 820
2021
Q4 		$2.67M Buy
124,198
+13,705
+12% +$591K 0.01% 794
2021
Q3 		$8.16M Buy
110,493
+4,071
+4% +$271K 0.02% 548
2021
Q2 		$5.82M Buy
106,422
+11,724
+12% +$702K 0.02% 665
2021
Q1 		$6.98M Buy
94,698
+11,420
+14% +$899K 0.02% 617
2020
Q4 		$7.18M Buy
83,278
+8,427
+11% +$507K 0.02% 610
2020
Q3 		$2.83M Buy
+74,851
New +$2.94M 0.01% 755

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Axa's ALXO Position: Q2 2022 in Review

Axa sold out of ALX Oncology (ALXO) in Q2 2022, closing a stake of 124,199 shares — an estimated $2.1M sold.

Axa first reported a position in ALXO in Q3 2020 and held it in 7 quarters. The position peaked at $8.16M in Q3 2021. 97 funds tracked by Wall St. Rank hold ALXO as of Q2 2022.

  • Axa reported no remaining ALX Oncology position as of Q2 2022 after selling out during the quarter.
  • Axa sold 124,199 ALX Oncology shares in Q2 2022, an estimated $2.1M.
  • Axa first reported a position in ALX Oncology in Q3 2020 and held it in 7 quarters.
  • Axa's ALX Oncology position peaked at $8.16M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.